Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease
Clinical trial NCT00660881 · COMPLETED
Trial details
- NCT number
- NCT00660881
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2011-12-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.